Abstracts can be submitted via the online Abstract Submission Service only
Submission
Submission opening: Wednesday 1 February 2012
Submission deadline: Wednesday 4 April 2012, midnight French time (CET) - Extended until Tuesday 10 April 2012, midnight French time ( CET)
Draft Status
If you do not click on the submit button (Step 4 of the abstract submission service), your abstract will be saved in Draft Status. You will then be able to review it and submit it at a later time (but only before the deadline).
NB: Abstracts that are in draft status after the deadline will not be considered for selection.
Changes and corrections
Once submitted, it is not possible to make any corrections to the abstract content or information (such as authors details, topic, correction of typos in the text, etc.). What can be done:
- During Submission Period - Online Submission service is open -
In order to correct your abstract you must withdraw it and submit a new corrected version prior to the deadline (See below for withdrawal procedure).
- After submission deadline - Online Submission service is closed -
Replacement of your abstract is not possible. Changes can not be made to the submitted version. In case of errors in your abstract, you may indicate the correction during the presentation at the congress (on your poster or oral presentation). However, changes will not be included in any of the publications (online, final programme, abstract-book / CD Rom...).
Withdrawal
If you want to withdraw an abstract already submitted, please notify us as quickly as possible at euroaccscientific@escardio.org stating the title and number of the abstract to be withdrawn.
Note that withdrawal is still possible after the submission deadline.
Step 1 - Abstract Information
Title
Maximum 200 characters typed in lower-case letters, except for abbreviations and study names. Please be careful that your title might be truncated if you copy and paste it into the field.
Topic
Select one topic from the list of topics which best describes the abstract content (for Abstract Evaluation). Make sure you select the appropriate topic as this choice will determine which graders will review your abstract.
Options
- No Option = Standard submission
- Young Investigators Award (YIA)
If you are 35 years or younger at the time of submission (4 April 2012), you may wish to present your abstract in the Young Investigators Awards (YIA) session.
Birth date cut-off for YIA Option: 10 April 1977.
Special note to YIA submitters:
If you are submitting the abstract on behalf of the first author/presenter, you must enter the first author’s birth date, as this date will be the qualifying point for the option validation. Abstracts with non eligible birth dates will be automatically removed from this option. Please tick the appropriate box in the Abstract Information section.
On behalf of
It is required that you enter the name of affiliation for your research. Do not list any author names in this field - only related organisation.
Acronyms
If the study to be presented is known through an acronym, please indicate the name of the study (e.g. "EMIT") in the appropriate field, as well as the full name of the acronym (e.g. "European Mizaverol Trial").
Step 2 - Abstract Authors and Institutions
Your abstract must list at least 1 author in order to be submitted.
Authors list
Please note that the first author should be the abstract Presenter by default. Nevertheless, it can be modified through the agreement form available online in June/July 2012. In all cases, the Presenter must be part of the authors list included in the submitted abstract. You may enter up to 10 authors in the authors list including the Presenter. The names of authors will be published as listed on the submission form. Please make sure the information given for each author is correct, as no changes will be possible after the abstract is submitted (see paragraph on changes and corrections above).
If none of the authors are able to present the abstract during the congress, the abstract should be withdrawn. If not, it will be considered as no-show and the Congress Programme Committee can then decide not to consider an abstract submitted by the same author the following year.
Institutions
This is a mandatory step.
You will be requested to select your institution when you create the presenter and the authors. Once you have entered your city, a list will automatically appear from which you can select your institution.
If your institution is not in the list, you have the possibility of creating it.
If your city is not in the list, please enter it, press enter then add your institution.
Step 3 - Abstract Content
All abstracts must be submitted in English with accurate grammar and spelling suitable for publication. If in doubt, please arrange for the review of your abstract by a native English speaker, by a university scientific publications office (or other similar facility) prior to submission.
Please note that any medical research involving human subjects must conform to the principles of the Declaration of Helsinki of the World Medical Association. We remind you that patient's photos should be avoided and the patient must never be identifiable in your presentation.
Do not cut and paste symbols into your text. Use the symbols provided when you click on the ©. Using "cut and copy" from another document can result in symbol not being correctly displayed.
Abstract body must be written in lower-case letters, except for abbreviations, study names or first letter of the sentence.
We recommend you structure your abstract as follows:
Purpose - Methods - Results - Conclusions
- There is not a specific maximum of words, but rather a maximum total size of the abstracts (shown as 100 %), including the text, table and picture (if any).
- The maximum abstract size is 35 lines of 75 characters (2625 characters)
- an image represents 11 lines (including the title)
- each table row represents 1 line (+ 3 lines for title and legend)
- table legend size is calculated by dividing its numbers of characters by 75.
- Use the save and refresh button at the bottom in order to display the size of the abstract in percentage (shown on the left side of the screen). The programme then converts the size in % to display to you when you register it as a draft.
- The character limit does not include the title and the authors. Only the abstract text, table and picture are taken into account.
Important: As the grading and selection process is blinded, the title and body text MUST NOT contain information such as:
- Title of the abstract
- Names (authors or other)
- Names of institute or company
- Web site and email addresses
This information will be automatically deleted by the abstract submission services.
Abstract table
The table field holds a table without surrounding text. Do NOT COPY your table into the field. You must RECREATE your table using the tools provided.
The maximum size of the table is 12 columns and 20 rows, and you can only enter one table. The title field is optional.
Abstract picture
Your picture file must meet the following criteria:
- Format: JPEG or GIF
- Size: less than 100 Kb
- Measures no larger than 500 pixels(x) x 200 pixels(y)
Please make sure that your picture is readable on the abstract preview (this represents how it will look in all publications). You can only enter one picture, and the title field is optional.
Step 4 - Abstract Preview and Submission
Please read through your abstract carefully before submitting it, as you cannot change it once submitted and we can not modify the content / author list / topic for you once it has been submitted.
Do not forget to click on the Submit button to validate your abstract submission. You will receive an automatic confirmation by email. If you do not receive this confirmation for one or more of your abstracts, please contact the Scientific Programmes Department here .
There is no limit to the number of abstracts an author may submit, but you should not submit the same research twice, even under a different topic. If you submit two abstracts with the same content, the abstract submission service will automatically keep the most recent abstract submitted and withdraw the other. Note that duplicate draft abstracts will not be deleted.
Abstract Results
- All abstracts will be reviewed by the members of the Abstract Review Committee (graders). The final selection will be made end of May 2012 (results announced 1 June 2012).
- All accepted abstracts will be scheduled either for an Oral Presentation or Poster Presentation. The Congress Programme Committee will determine the format, day and time of presentation (Assigned presentation times / dates can not be changed.)
- An email message will be sent to the Abstract Submitter 1st June 2012 with a report on the status of the abstract (accepted or rejected).
- If the abstract is accepted, the submitter will receive instructions concerning the presentation format and process to submit agreement form.
- Same presenter cannot be assigned to more than 3 abstracts - co-authors should then be assigned as presenters.
- Submission of an abstract constitutes a commitment by the author(s) to present if accepted. Failure to present and register for the Congress, if not justified, may jeopardize future acceptance of abstracts.
Important Information
Embargo
Accepted abstracts are under embargo until one week before the Congress.
During embargo, accepted abstracts should not be published in any other journals and/or online publications or presented at any international congresses. Submitting or presenting published work may jeopardize future acceptance of abstracts.
Publication of Abstracts
Accepted abstracts are under embargo until one week before the congress. At that time they will be available on the Scientific Programme Online.
All accepted abstracts will be published in the abstract supplement of the European Heart Journal - Acute CardioVascular Care.
Affirmation of Originality and Copyright transfer statement
- The submitter hereby affirms that the work submitted is original, except for extracts from copyrighted works fully authorised by the copyright holders, and that all statements declared as facts are based on thorough examination and investigation for accurateness.
- By submitting your work to the ESC, you consent to have authors’ names, affiliation and biographical material being used in connection with the publication of your work.
- Author(s) represents and warrants that he/she/they is/are sole author(s) of the work, that all authors have participated in and agree with the content and conclusions of the work, and that the work is original and does not infringe upon any copyright, proprietary, or personal right of any third party.
- Submitted abstracts should not have been presented at any previous international congress. However, former presentation at national meetings does not disqualify. An author submitting or presenting published work may jeopardize future acceptance of abstracts.
- The content belongs to the author(s). However if the abstract is accepted the submitter agrees, on behalf of all co-authors, to transfer and assign to the ESC the rights to edit, publish, reproduce, distribute copies and prepare derivative works such as press release. This includes use in indexes or search databases in print, electronic, or other media.
- Author(s) retain the right, after presentation at the Congress, to subsequently include the work in articles, books, or derivative works that he/she authors or edits provided said use does not imply the endorsement of the ESC.
- The submitter signs for all co-authors and accepts responsibility on the present rules for submission and presentation for transferring copyright on behalf of all co-authors.
Conflict of interest
The Congress Programme Committee requests speakers, chairpersons and poster presenters to disclose potential conflict of interest. Abstract Presenters are requested to disclose potential conflicts of interest regarding their presentation in the first slide. Poster presenters are requested to disclose potential conflicts of interest regarding poster presentation at the bottom of their poster. This will allow the audience to take potential conflicts of interest into account when assessing the objectivity of the presentation.
A potential conflict of interest may arise from various relationships, past or present, such as employment, consultancy, investments and stock ownership, funding for research, family relationship, etc.
Data Privacy
By certifying that you have read these Submission rules, you also confirm having received the prior approval from the co-authors to provide their data to the ESC. You have personal data, which is, according the Law on data processing and Civil Liberties 78-17 of 6 January 1978 modified, registered with the European Society of Cardiology (ESC). The information you supply on this application is required to process it and it will be held in the ESC customer data files. It may be used for marketing and communication purposes by the ESC and its contractors only. You have the absolute right to access, amend and oppose any use of this personal data by writing to the ESC at the address mentioned below
THE EUROPEAN HEART HOUSE
2035 Route des Colles
Les Templiers BP 179
06903 Sophia Antipolis - France